Valeant Product Producer Progenics Announce European Approval For RELISTOR To Treat All Opioid Induced Constipation
June 03, 2015 at 07:50 AM EDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX:VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced ...